top of page

DAC FAQ 12 May 2023

stevecutts
May 12, 2023
3 min read

Updated: Oct 23

About this archived OECD FAQ

The attached OECD FAQ is dated September 2022 and was preserved on this site under the reference date 12 May 2023. This HTML guide summarises its twelve answers in new wording. It presents the OECD's position at that time, rather than endorsing it or updating it to today's rules. The original PDF remains available below.

1. Why did the DAC change ODA accounting?

The OECD argued that a wider range of development-finance tools required updated measurement. It presented the move from net cash flows to loan grant equivalents as a way to distinguish a grant from a loan and to reflect differences in lending terms. Cash-flow data continued to be collected alongside the headline measure.

2. How did the rule-making process work?

The FAQ described research, expert input, discussion and negotiation among members, with consensus needed for decisions. It cited an Expert Reference Group and publicly circulated papers as evidence for its claims about transparency and participation.

3. Did measurement and aid quality improve?

The OECD defended the reforms as more consistent and transparent, while acknowledging that a consensus-based system could be improved. It pointed to activity-level reporting, peer reviews and evaluations. It treated measurement quality and the effectiveness of aid as related but distinct questions.

4. How were private sector instruments treated?

The FAQ explained that members had agreed principles in 2016 but had not settled all implementation details. Provisional arrangements combined PSI net disbursements with grant equivalents for other categories. It distinguished official support from private finance mobilised by that support, which was reported separately.

5. What happened to headline ODA volumes?

The OECD accepted that grant equivalents and net cash flows would produce different long-term totals, but said aggregate annual effects had been modest in the years examined. It also acknowledged that effects could be appreciably larger for individual donors.

6. Why use those discount rates?

The FAQ defended rates differentiated by recipient income group and based on an IMF-related starting point. It emphasised predictable reporting and budget planning, described a trade-off between stability and precision, and promised review. It did not accept export-credit discount rates as a universally decisive benchmark.

7. Was loan risk counted twice through debt relief?

The OECD rejected that criticism. Its answer said debt-restructuring reporting captured additional concessionality and was subject to ceilings intended to limit inflation. It also cited parallel cash-flow reporting as a transparency mechanism. This is a central point disputed in ODA Reform's response.

8. Would the system encourage loans instead of grants?

The FAQ said the available evidence did not show a major shift in donor behaviour and described grants as the dominant form of aid. It referred to minimum concessionality requirements and debt-sustainability safeguards as protections against inappropriate lending.

9. How did the reforms relate to climate finance?

The OECD distinguished DAC grant-equivalent accounting from broader climate-finance totals and multilateral bank lending. It emphasised the UNFCCC's role in climate-finance reporting and noted the option of providing grant-equivalent information alongside flow data.

10. Why count relief on debt that was not originally ODA?

The FAQ described this as an established practice predating modernisation. It justified eligibility through debt relief's developmental purpose and its contribution to reducing recipients' debt burdens, including in the context of sustainable-development commitments.

11. What about equity profits and receipts?

The answer defended development-oriented equity reporting under the provisional PSI arrangements. It described a cap on reflows and said members supplied sale and dividend information for oversight. The implications of caps and returns are examined elsewhere on this site.

12. Why count surplus COVID-19 vaccine donations?

The OECD treated the donations as aid in kind and defended the guidance on valuation and safeguards. For 2021 it used a recommended value of US$6.72 per dose, with adjustments where needed to avoid overstatement. Expired doses were excluded, and the guidance normally required at least ten weeks of shelf life on arrival.

Compare the original and the response

The PDF contains the full OECD answers, figures, qualifications and original references. Steve Cutts's point-by-point response is available here: https://www.odareform.org/post/point-by-point-repudiation-of-the-oecd-faq-defending-oda-accounting

For the separate analysis of surplus vaccines, see: https://www.odareform.org/post/oda-and-the-donation-of-surplus-covid-vaccines

 
 
 

Comments


bottom of page